• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHONG Suyue,TAN Qiulong,YAO Xuanbao,YANG Jiaying,XIAO Shifeng.The overview of techniques of AD drug developments targeting tau protein[J].Journal Of Pharmaceutical Research,2022,41(2):122-126[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2400times   Download 2093次 QR Code for this article
Scan with your phone!
基于tau蛋白的阿尔茨海默病药物研发方法概述
仲苏月,谭秋龙,姚炫豹,杨佳颖,肖时锋
Font:Larger+|Default|Smaller-
(深圳大学生命与海洋科学学院,广东 深圳 518060)
摘要:
阿尔茨海默病(Alzheimer’s disease,AD)是一种表现为记忆、认知障碍并伴随焦虑情绪的神经退行性疾病。由淀粉样β蛋白组成的老年斑和tau蛋白形成的神经纤维缠结是阿尔茨海默病主要的分子病理特征。Tau病理是阿尔茨海默病发病机制的主要假说之一,成为药物研发者的关注重点。本文就当前以tau蛋白为靶点的阿尔茨海默病药物研发进行了分析,在分子、细胞、整体动物以及计算机辅助药物研发水平上总结了临床前实验中常用的研究模型及评价方法,概述不同模型的利弊并展望其未来发展方向。
关键词:  阿尔茨海默病  Tau蛋白  磷酸化  蛋白质聚集  计算机辅助药物设计  药物研发
DOI:10.13506/j.cnki.jpr.2022.02.012
基金项目:深圳市基础研究学科布局项目(No.JCYJ20180507182417779)
Publication Date:February 25, 2022
The overview of techniques of AD drug developments targeting tau protein
ZHONG Suyue,TAN Qiulong,YAO Xuanbao,YANG Jiaying,XIAO Shifeng
(College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China)
Abstract:
Alzheimer’s disease (AD) is a neurodegenerative disease with memory and recognition defects and anxiety. The senile plaque formed by amyloid β-protein (Aβ) and neurofibrillary tangles containing tau protein are the main pathological characteristics. Tau hypothesis is one of the most accepted AD mechanisms. As most potential drugs targeting Aβ failed in clinical trials recently, tau protein attracts much more attention. Based on the recent studies on AD drug developments, this review summarizes the models and techniques used in molecular, cellular, mouse, and computational researches. We further evaluate the advantages and disadvantages of each model and prospect the future directions.
Key words:  Alzheimer’s disease  tau protein  Phosphorylation  Protein aggregation  Computer aided drug design  Drug development
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.